Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SI-BONE Inc SIBN

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and... see more

Recent & Breaking News (NDAQ:SIBN)

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

GlobeNewswire January 30, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

GlobeNewswire January 8, 2024

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

GlobeNewswire November 14, 2023

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

GlobeNewswire November 6, 2023

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

GlobeNewswire November 1, 2023

SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023

GlobeNewswire October 16, 2023

SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods

GlobeNewswire September 5, 2023

SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023

GlobeNewswire August 29, 2023

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance

GlobeNewswire August 7, 2023

SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023

GlobeNewswire July 19, 2023

SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023

GlobeNewswire July 17, 2023

SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023

GlobeNewswire May 24, 2023

SI-BONE Announces Pricing of Public Offering of Common Stock

GlobeNewswire May 4, 2023

SI-BONE Announces Launch of Public Offering of Common Stock

GlobeNewswire May 4, 2023

SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance

GlobeNewswire May 1, 2023

SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference

GlobeNewswire April 24, 2023

SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023

GlobeNewswire April 10, 2023

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance

GlobeNewswire February 27, 2023

SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023

GlobeNewswire February 6, 2023

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022

GlobeNewswire January 9, 2023